Plymouth, MN – According to filings with the U.S. Securities and Exchange Commission, Reprise Biomedical is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Carrie Powers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Reprise Biomedical

Reprise Biomedical, Inc. is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.

To learn more about Reprise Biomedical, visit http://www.reprisebio.com/

Contact:
Carrie Powers, President and Chief Executive Officer
763-284-6780
https://www.linkedin.com/in/carrie-powers-98440411/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved